Your browser doesn't support javascript.
loading
Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms.
Chatzellis, Eleftherios; Angelousi, Anna; Daskalakis, Kosmas; Tsoli, Marina; Alexandraki, Krystallenia I; Wachula, Ewa; Meirovitz, Amichay; Maimon, Ofra; Grozinsky-Glasberg, Simona; Gross, David; Kos-Kudla, Beata; Koumarianou, Anna; Kaltsas, Gregory.
Afiliação
  • Chatzellis E; 1st Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece, e.chatzellis@endo.gr.
  • Angelousi A; 251 HAF and VA Hospital, Athens, Greece, e.chatzellis@endo.gr.
  • Daskalakis K; 1st Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Tsoli M; 1st Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Alexandraki KI; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Wachula E; 1st Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Meirovitz A; 1st Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Maimon O; Department of Clinical Oncology and Radiotherapy, Medical University of Silesia, Katowice, Poland.
  • Grozinsky-Glasberg S; Oncology Department and Radiation Therapy Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Gross D; Oncology Department and Radiation Therapy Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Kos-Kudla B; Neuroendocrine Tumour Unit, Endocrinology and Metabolism Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Koumarianou A; Neuroendocrine Tumour Unit, Endocrinology and Metabolism Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Kaltsas G; Department of Endocrinology and Neuroendocrine Neoplasms, Department of Endocrinology and Pathophysiology, Medical University of Silesia, Katowice, Poland.
Neuroendocrinology ; 109(4): 333-345, 2019.
Article em En | MEDLINE | ID: mdl-31167197
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Tumores Neuroendócrinos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Neuroendocrinology Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Tumores Neuroendócrinos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Neuroendocrinology Ano de publicação: 2019 Tipo de documento: Article